London and Boston (OTE) - Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines.

London (OTE) - Isomorphic Labs will utilise the funding to further power its AI drug design engine through frontier AI research and development and to scale and progress its drug candidate pipeline.